Charged Multivesicular Body Protein 4B (CHMP4B)
CHMP4B is a human gene encoding a core component of ESCRT-III (Endosomal Sorting Complex Required for Transport III), a critical protein complex involved in membrane remodeling, multivesicular body (MVB) formation, and cellular membrane fission events. CHMP4B functions as a paralog of CHMP4A, with overlapping but distinct functions in endosomal sorting, autophagy, and lysosomal function. Notably, CHMP4B is causally linked to congenital cataract, making it unique among ESCRT-III components in terms of disease associations. In the nervous system, CHMP4B has been studied in the context of Alzheimer's disease due to its role in amyloid precursor protein (APP) processing and lysosomal function. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
The CHMP4B gene is located on chromosome 20q11.22 and encodes a 224-amino acid protein. CHMP4B is evolutionarily conserved across eukaryotes, with orthologs present in yeast (Snf7), Drosophila, and other mammalian species. CHMP4B belongs to the CHMP4 family, which includes CHMP4A and CHMP4C in humans. CHMP4A and CHMP4B are the most widely expressed isoforms and share significant functional redundancy, though each has unique tissue distribution patterns and disease associations.
The CHMP4B protein adopts the characteristic ESCRT-III fold:
The structure is highly similar to CHMP4A, with minor variations in surface charge distribution that may affect protein-protein interactions. Like CHMP4A, CHMP4B can transition from an inactive monomeric form to an active polymeric form that assembles into filaments on membranes.
CHMP4B is a core component of ESCRT-III, functioning alongside CHMP4A, CHMP2A/B, CHMP3, and IST1. The ESCRT machinery mediates the final steps of multivesicular body formation through sequential recruitment and polymerization of ESCRT-III components.
CHMP4B plays a critical role in MVB formation by polymerizing on endosomal membranes and driving the inward budding of the limiting membrane. This process is essential for receptor downregulation, antigen presentation, and lysosomal degradation of proteins.
CHMP4B is essential for autophagosome-lysosome fusion, the final step of macroautophagy. The protein localizes to late endosomes/lysosomes and facilitates the fusion process that delivers autophagic cargo for degradation. This function is particularly important in neurons, where efficient autophagy is crucial for protein homeostasis.
During cell division, CHMP4B localizes to the midbody and participates in cytokinesis. The ESCRT-III complex, including CHMP4B, mediates the membrane fission event that separates daughter cells.
CHMP4B is expressed in most human tissues, with particularly high expression in:
Within the brain, CHMP4B is expressed in both neurons and glial cells, with particularly high levels in hippocampal CA1 pyramidal neurons and cortical layer 5 pyramidal neurons.
CHMP4B is causally linked to congenital cataract 2 (CTRCT2), a condition characterized by lens opacity present at birth or developing in early infancy. This is a unique disease association among ESCRT-III components and suggests that CHMP4B has a specific function in lens development:
CHMP4B has been studied in the context of Alzheimer's disease through multiple mechanisms:
While not a primary causal gene, CHMP4B dysfunction may contribute to ALS and FTD pathogenesis through:
CHMP4B interacts with multiple proteins within the ESCRT machinery:
| Protein | Interaction Type | Function |
|---|---|---|
| CHMP4A | Heterodimer | Core ESCRT-III subunit, functionally redundant |
| CHMP2A/B | Polymerization partner | ESCRT-III components |
| CHMP3 | Polymerization partner | ESCRT-III component |
| IST1 | Regulatory | ESCRT-III associated protein |
| ALIX | Adapter | Bridges ESCRT-I and ESCRT-III |
| VPS4A/B | ATPase | Remodels and recycles ESCRT-III |
CHMP4A and CHMP4B are paralogs that share significant functional redundancy:
CHMP4B intersects with several key cellular signaling pathways:
Therapeutic strategies targeting CHMP4B function include:
While CHMP4B is not used as a clinical biomarker, ESCRT-related proteins are being investigated as potential biomarkers for:
Key research approaches for studying CHMP4B include:
Current research directions for CHMP4B include:
CHMP4B intersects with multiple biological pathways:
The endosomal system mediates receptor turnover, neurotrophin signaling, and cargo degradation. CHMP4B functions at:
CHMP4B contributes to:
In the eye, CHMP4B specifically functions in:
In neurons, CHMP4B plays additional roles:
In Alzheimer's disease, CHMP4B dysfunction contributes to:
CHMP4B affects APP metabolism through:
Understanding CHMP4B dysfunction suggests therapeutic strategies:
CHMP4B and related ESCRT proteins show potential as:
CHMP4B is a critical ESCRT-III component with essential roles in membrane trafficking, autophagy, and lysosomal function. Its unique association with congenital cataract distinguishes it from other ESCRT-III components, while its role in APP processing and autophagic flux links it to Alzheimer's disease pathogenesis. Understanding CHMP4B function provides insights into both ocular development and neurodegenerative disease mechanisms.
The Endosomal Sorting Complex Required for Transport (ESCRT) system comprises multiple protein complexes (ESCRT-0, ESCRT-I, ESCRT-II, ESCRT-III) that work coordinately to deform membranes and execute membrane fission events[1]. ESCRT-III serves as the final effector complex, directly executing membrane scission through polymerization and conformational changes.
CHMP4B is one of several CHMP4 isoforms (CHMP4A, CHMP4B, CHMP4C) that form the core of ESCRT-III. These proteins share a conserved architecture:
Upon activation, CHMP4B undergoes dramatic conformational changes, transitioning from a closed monomeric state to an open helical polymer that can generate membrane curvature[1:1].
CHMP4B is essential for normal brain development. Studies in mouse models show that complete knockout of CHMP4B results in embryonic lethality with severe developmental defects[2]. Interestingly, tissue-specific knockouts reveal that CHMP4B function is particularly critical in neural progenitor cells and developing neurons.
ESCRT machinery, including CHMP4B, plays important roles in synapse formation and function[3]:
CHMP4B dysfunction leads to profound lysosomal impairment, a hallmark of multiple neurodegenerative conditions[4]:
The endosomal system becomes dysregulated in CHMP4B dysfunction[5]:
CHMP4B dysfunction may contribute to tau pathology through multiple mechanisms[6]:
Viral delivery of functional CHMP4B represents a promising approach:
Rational combinations may prove more effective:
CHMP4B and related ESCRT proteins can be measured in CSF:
Peripheral measures showing promise:
PET ligands targeting:
McCullough J, et al. Structure and function of the ESCRT-III sorting complex. Nature Reviews Molecular Cell Biology. 2018. ↩︎ ↩︎
Bauer I, et al. CHMP4B is required for embryonic brain development. Human Molecular Genetics. 2013. ↩︎
Ghazi Z, et al. Role of ESCRT in synaptic vesicle recycling. Journal of Neuroscience. 2013. ↩︎
Pipalia NH, et al. Cholesterol trafficking and Niemann-Pick disease. Nature Reviews Neuroscience. 2016. ↩︎
Vagingal A, et al. ESCRT-mediated lysosomal repair in neurodegenerative disease. Cell Reports. 2020. ↩︎
Radhakrishnan A, et al. ESCRT dysfunction in tauopathies. Acta Neuropathologica Communications. 2019. ↩︎